我要向钱看
commented on a stock · Dec 17 21:04
UPDATES
$Immuneering (IMRX.US)$ Immuneering To Present Phase 2a Trial Data For IMM-1-104 In First-Line And Second-Line Pancreatic Cancer, Along With Phase 1 Data For IMM-6-415, At Virtual Investor Event In January 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
105751862 : Let's all work hard together and defeat the Short Sellers.